3 Dirt-Cheap Healthcare Stocks to Buy Right Now

Bargain prices and tremendous growth prospects make these stocks really attractive.

Should You Buy These 3 Dirt-Cheap Stocks?

A stock can be cheap but not be a bargain. At least two of these stocks appear to be both.

5 Healthcare Stocks That Haven't Been This Cheap in at Least 10 Years

The coronavirus crash has pushed forward price-to-earnings ratios for these healthcare companies down to between 3 and 7.

Coronavirus Stock Market Crash: 3 Stocks You Need to Own

Significant pullbacks in the market have always been an opportune time to put your money to work.

3 No-Brainer Coronavirus Bear Market Buys

Buy, hold, and profit big-time from these three solid business models.

Have $1,000? Then Buy These Top Stocks Right Now

If you have disposable income to invest, now is the time to put it to work on some big-name bargains.

The Biggest Biotech Is Facing Profitability Worries — Is It Time To Buy Amgen Stock?

Amgen stock is facing concerns that its adjusted earnings will slide in 2020. Is it time to buy shares of the biotech company? The post The Biggest Biotech Is Facing Profitability Worries — Is It Time

Is Apellis Pharmaceuticals a Buy?

The pre-commercial company is looking to take on a $23 billion industry leader. Promising late-stage clinical results suggest it may have a shot.

Alexion Pharmaceuticals Inc (ALXN) Q4 2019 Earnings Call Transcript

ALXN earnings call for the period ending December 31, 2019.

3 Top Biotech Stocks to Buy Right Now

Here are three biotech companies with solid, revenue-driving products to add to portfolios while the price is right.

Alexion Stumbles On Mixed Outlook Despite Strong Fourth-Quarter Earnings

Alexion Pharmaceuticals topped Wall Street's fourth-quarter revenue and adjusted earnings expectations early Thursday, but Alexion Pharma stock slipped on mixed guidance for 2020. The post Alexion

6 Industries That Are Historically Cheap, Even With the Stock Market at an All-Time High

Many of these industries have recently been valued at their lowest forward P/E in at least 22 years.

2 Biotechs Battling Immune Diseases

Duking it out in two immune-related diseases, these biotechs couldn’t be more different.

Stock Market Rally Powers Higher Despite Iran Tensions; Tesla, Boeing, Costco, Beyond Meat In Focus: Weekly Review

The stock market rally hit new highs despite an Iran missile attack. Tesla, Costco and Beyond Meat rallied. A Boeing 737 crash was just one of several big headlines for the aerospace giant. The post

Red-Hot Biotech Stocks Brace For Key Meeting — Here's What To Expect

If biotech stocks were red hot at the end of 2019, expect them to be scorching next week. The J.P. Morgan Health Care Conference kicks off next Monday in San Francisco, Calif. The post Red-Hot Biotech

Here's Why Apellis Pharmaceuticals Stock Jumped as Much as 40.7% Today

The company's lead drug candidate bested a competitor's therapy on a key endpoint in a phase 3 trial.

This Biotech Just Topped Alexion's Biggest Moneymaker — And Rocketed

Shares of Apellis Pharmaceuticals rocketed Tuesday after the biotech company's experimental drug outperformed Alexion Pharmaceuticals' blockbuster, Soliris, in a head-to-head test. The post This

Apellis' Lead Drug Tops Alexion's Blockbuster Soliris in a Pivotal Late-Stage Study

Pegcetacoplan is the first drug to beat Soliris in improving hemoglobin levels in PNH patients.

4 No-Brainer Large-Cap Stocks to Own in 2020

These large-cap growth and value stocks could make you richer this year.

Here's Why Dicerna Pharmaceuticals Is Falling Today

What goes up must come down. But today's tumble means relatively little for investors with a long-term mindset.